1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Ukraine Pharmaceuticals and Healthcare Report Q3 2016

Ukraine Pharmaceuticals and Healthcare Report Q3 2016

  • July 2016
  • -
  • Business Monitor International
  • -
  • 82 pages

Includes 3 FREE quarterly updates

BMI View: Wide-scale changes to the regulatory environment of Ukraine's pharmaceutical sector willincrease its attractiveness to multinational pharmaceutical manufactures. The introduction of referencepricing will aid in improving medicine affordability and accessibility, driving increased demand, whilechanges to medicine registration will reduce market access barriers.Headline Expenditure ProjectionsPharmaceuticals: UAH46.8bn (USD2.14bn) in 2015 to UAH52.1bn (USD2.11bn) in 2016; +11.2% inlocal currency terms and -1.1% in US dollar terms. Forecast revised downwards compared to the previousquarter.Healthcare: UAH103.1bn (USD4.70bn) in 2015 to UAH101.9bn (USD4.13bn) in 2016; -1.2% in localcurrency terms and -12.1% in US dollar terms. Forecast revised downwards compared to the previousquarter.

Table Of Contents

Ukraine Pharmaceuticals and Healthcare Report Q3 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Ukraine 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Ukraine 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Ukraine 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Ukraine 2012-2020) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Ukraine 2012-2020) 16
Prescription Drug Market Forecast 17
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Ukraine 2012-2020) 18
Patented Drug Market Forecast 19
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Ukraine 2012-2020) 20
Generic Drug Market Forecast 21
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Ukraine 2012-2020) 22
OTC Medicines Market Forecast 23
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Ukraine 2012-2020) 24
Pharmaceutical Trade Forecast 25
Table: Pharmaceutical Trade Data And Forecasts (Ukraine 2014-2020) 26
Table: Pharmaceutical Trade Data And Forecasts local currency (Ukraine 2014-2020) 27
Industry Risk/Reward Index 28
Central And Eastern Europe Risk/Reward Index - Q3 2016 28
Ukraine Risk/Reward Index 34
Rewards 34
Risks 35
Regulatory Review 36
Recent Regulatory Developments 38
Intellectual Property Issues 41
Pricing Regime 42
Reimbursement Regime 45
Market Overview 47
Healthcare System 48
Table: Healthcare Resources (Ukraine 2010-2015) 51
Table: Healthcare Personnel (Ukraine 2010-2015) 51
Table: Healthcare Activity (Ukraine 2010-2015) 52
Research And Development 52
Clinical Trials 53
Epidemiology 54
Competitive Landscape 58
Research-Based Industry 58
Table: Association of International Manufacturers (AIPM) Ukraine Members, 2015 59
Table: Multinational Market Activity 60
Generic Drugmakers 61
Pharmaceutical Distribution 63
Pharmaceutical Retail Sector 64
Company Profile 66
Arterium 66
Farmak 69
Demographic Forecast 71
Table: Population Headline Indicators (Ukraine 1990-2025) 72
Table: Key Population Ratios (Ukraine 1990-2025) 72
Table: Urban/Rural Population and Life Expectancy (Ukraine 1990-2025) 73
Table: Population By Age Group (Ukraine 1990-2025) 73
Table: Population By Age Group % (Ukraine 1990-2025) 74
Glossary 76
Methodology 78
Pharmaceutical Expenditure Forecast Model 78
Healthcare Expenditure Forecast Model 78
Notes On Methodology 79
Risk/Reward Index Methodology 80
Index Overview 81
Table: Pharmaceutical Risk/Reward Index Indicators 81
Indicator Weightings 82

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Prostate Cancer Pricing, Reimbursement, and Access

Prostate Cancer Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

Novel antiandrogens will need to present risk-sharing agreements in EU markets, while discussing contracting with US payers to ensure a competitive advantage. Vaccines suffer from inconclusive response ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7 000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

IMS World Review Executive™ 2016

IMS World Review Executive™ 2016

  • $ 6 860
  • Industry report
  • July 2016
  • by IMS Health

IMS World Review ExecutiveTM 2016 provides essential insights into worldwide sales of the pharmaceutical market, interlocking market trends and sales analysis from 2011 to 2015, including the breakdown ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.